Atlas Trials

Irradiated Donor Lymphocyte Infusion Plus High-dose IL-2

Clinical trial NCT01925118 · TERMINATED

Trial details

NCT number
NCT01925118
Sponsor
Seoul National University Hospital
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Malignant Melanoma and Renal Cell Carcinoma
Start date
2013-08-01
Primary completion
2015-05-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.